Vanda Pharmaceuticals Inc.
VNDA | NASDAQ
$5.21
+$0.05 (+1.07%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 84.85M | 102.32M | 135.82M | 135.03M | 52.07M | 61.03M |
Short-Term Investments | 179M | 272.33M | 252.44M | 331.83M | 380.74M | 306.71M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 11.08M | 9.1M | 9.99M | 11.38M | 8.15M | 6.64M |
Receivables | 54.58M | 47.1M | 34.16M | 33.51M | 32.47M | 30.04M |
Inventory | 1.85M | 1.73M | 1.36M | 1.19M | 1.02M | 1.28M |
Other Current Assets | 26.99M | 15.42M | 9.17M | 17.73M | n/a | n/a |
Total Current Assets | 347.26M | 438.89M | 432.95M | 519.29M | 478.3M | 409.15M |
Property-Plant & Equipment | 13.51M | 12.68M | 9.14M | 10.97M | 12.39M | 14.6M |
Goodwill & Intangibles | 117.09M | 114.1M | 121.37M | 18.57M | 20.08M | 21.56M |
Total Long-Term Assets | 141.69M | 217.31M | 215.49M | 114.96M | 115.49M | 124.31M |
Total Assets | 488.95M | 656.2M | 648.44M | 634.25M | 593.79M | 533.46M |
Account Payables | 4.94M | 3.5M | 7.15M | 12.69M | 925K | 1.05M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 87.19M | 69.36M | 69.33M | 34.01M | 27.68M | 45.38M |
Total Current Liabilities | 145.16M | 99.98M | 87.7M | 91.44M | 74.42M | 65.94M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 9.53M | 9.59M | 8.83M | 6.8M | 4.39M | 2.76M |
Total Long-Term Liabilities | 16.6M | 17.68M | 15.83M | 15.61M | 14.45M | 14.25M |
Total Liabilities | 161.76M | 117.66M | 103.53M | 107.05M | 88.86M | 80.19M |
Total Debt | 12.62M | 12.36M | 9.4M | 11.14M | 12.37M | 13.61M |
Book Value | 327.19M | 538.55M | 544.91M | 527.2M | 504.93M | 453.27M |
Book Value Per Share | 5.55 | 9.26 | 9.47 | 9.25 | 8.87 | 8.21 |
Common Stock | 59K | 58K | 58K | 57K | 56K | 55K |
Retained Earnings | -394.77M | -174.29M | -155.39M | -157.9M | -164.18M | -197.33M |
Comprehensive Income | 629K | 74K | -30K | -1.19M | -175K | 239K |
Shareholders Equity | 327.19M | 538.55M | 544.91M | 527.2M | 504.93M | 453.27M |
Total Investments | 179M | 272.33M | 252.44M | 331.83M | 380.74M | 306.71M |
Add to Watchlist
Select watchlists to add or remove VNDA